新生儿脉搏血氧筛查恢复、阳性与阴性结果的临床结局
这项基于芬兰东部的队列研究纳入2012—2019年16 599例胎龄≥35周、生后2~6小时完成早期脉搏血氧筛查的无症状新生儿。筛查阴性16 160例(97.4%),恢复208例(1.3%),阳性231例(1.4%)。与阴性结果相比,恢复和阳性结果均与NICU入住及生后7天继续住院风险升高相关;恢复结果还与生后72小时内抗生素暴露和呼吸支持风险升高相关。恢复组中未发现危重先天性心脏病,但呼吸系统疾病、脓毒症和低血糖较阴性组更常见。
要点
- 恢复组NICU入住风险为阴性组的5.62倍(95%CI 4.58-6.91),阳性组为13.04倍(95%CI 11.77-14.44)。
- 恢复组生后7天继续住院风险为阴性组的4.70倍(95%CI 3.07-7.19),阳性组为11.97倍(95%CI 9.26-15.47)。
- 恢复组生后72小时内抗生素暴露风险为阴性组的5.45倍(95%CI 3.94-7.52),呼吸支持需求风险为10.16倍(95%CI 3.53-29.21)。
- 恢复组呼吸系统疾病发生率为13.0%(27/208),脓毒症为4.8%(10/208),低血糖为8.2%(17/208),均高于阴性组。
- 恢复组中未出现危重先天性心脏病,提示初筛不确定后转阴的新生儿主要风险在非心脏性可治疗疾病。
适用人群与场景
- 胎龄≥35周、生后2~6小时完成早期脉搏血氧筛查的无症状新生儿。
- 来自芬兰东部一所三级大学医院,2012年1月1日至2019年12月31日出生。
- 排除原文未提及的其他特定排除标准。
诊断标准与关键阈值
- 脉搏血氧筛查阴性:原文未提及具体血氧阈值。
- 脉搏血氧筛查恢复:初筛阳性或结果不确定,重复检测后转为阴性。
- 脉搏血氧筛查阳性:原文未提及具体血氧阈值。
- 结局定义:NICU入住、生后7天继续住院、生后72小时内抗生素暴露、呼吸支持需求、呼吸系统疾病、脓毒症、低血糖、危重先天性心脏病。
处置流程与药物剂量
- 原文未提供针对恢复或阳性结果的具体处置流程或药物剂量。
- 研究为观察性设计,未规定床旁干预步骤。
红旗征与不能漏的情况
- 初筛阳性或不明确即使复查转阴,也需警惕生后72小时内抗生素暴露和呼吸支持需求升高。
- 恢复组呼吸系统疾病、脓毒症和低血糖发生率高于阴性组,需关注可治疗性新生儿疾病而非仅排查先心病。
研究设计与关键结果
- 共16 599例新生儿纳入,女性8 349例(50.3%),平均胎龄39.8周(SD 1.3周);脉搏血氧筛查阴性16 160例(97.4%),恢复208例(1.3%),阳性231例(1.4%)。
- 与阴性组相比,恢复组NICU入住ARR为5.62(95%CI 4.58-6.91),阳性组ARR为13.04(95%CI 11.77-14.44)。
- 与阴性组相比,恢复组生后7天继续住院ARR为4.70(95%CI 3.07-7.19),阳性组ARR为11.97(95%CI 9.26-15.47)。
- 与阴性组相比,恢复组生后72小时内抗生素暴露ARR为5.45(95%CI 3.94-7.52),呼吸支持需求ARR为10.16(95%CI 3.53-29.21)。
- 恢复组呼吸系统疾病27例(13.0%)对比阴性组214例(1.3%),脓毒症10例(4.8%)对比127例(0.8%),低血糖17例(8.2%)对比565例(3.5%);恢复组中无危重先天性心脏病。
- 关联分析采用改良Poisson回归,校正母亲年龄、产次、体重指数、孕期吸烟以及新生儿性别、胎龄和出生体重Z评分。
证据类型、等级与局限
- 基于人群的队列研究。
- 局限:单中心研究;恢复组样本量较小(208例);观察性设计不能确立因果;原文建议需前瞻性研究验证。
对床旁实践的改变
- 对初筛不确定后转阴的新生儿,不能仅因复查转阴就视为完全正常,应关注呼吸、感染和低血糖等非心脏性风险。
- 恢复结果与NICU入住和7天继续住院风险升高相关,可用于床旁风险沟通和住院决策参考。
- 恢复组未发现危重先天性心脏病,提示复查转阴后对先心病的排查优先级可能低于对可治疗性疾病的评估。
- 本研究结论来自无症状、胎龄≥35周、生后2~6小时完成筛查的新生儿,不能直接外推到其他筛查时间或高危人群。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Pulse oximetry screening (POS) detects critical congenital heart defects (CCHDs) and other neonatal morbidities, but the clinical significance of initially abnormal results that normalize on repeat testing remains unclear.
OBJECTIVE: To assess the prevalence and clinical implications of positive, recovered, and negative early POS results in asymptomatic newborns.
DESIGN, SETTING, AND PARTICIPANTS: This population-based cohort study included asymptomatic neonates born at 35 weeks' gestation or later who underwent early POS at 2 to 6 hours of age at a tertiary-level university hospital in Eastern Finland between January 1, 2012, and December 31, 2019. Data were analyzed from August 2025 to August 2026.
EXPOSURE: Positive POS result or indeterminate POS result that normalized to a negative POS result (recovered) with repeat testing.
MAIN OUTCOMES AND MEASURES: Primary outcomes were neonatal intensive care unit (NICU) admission and continued hospitalization at 7 days; secondary outcomes included diagnostic investigations and neonatal morbidities. Associations between POS screening results and outcomes were examined using modified Poisson regression adjusted for maternal age, parity, body mass index, and cigarette smoking during pregnancy and newborn sex, gestational age, and birth weight Z score.
RESULTS: The cohort included 16 599 newborns born at 35 weeks' gestation or later who underwent early POS at 2 to 6 hours of age (8349 [50.3%] female; mean [SD] gestational age, 39.8 [1.3] weeks). POS results were negative in 16 160 newborns (97.4%), recovered in 208 (1.3%), and positive in 231 (1.4%). Compared with a negative POS result, a recovered or positive POS result was associated with higher risk of NICU admission (adjusted risk ratio [ARR], 5.62 [95% CI, 4.58-6.91] and 13.04 [95% CI, 11.77-14.44], respectively) and continued hospitalization at 7 days (ARR, 4.70 [95% CI, 3.07-7.19] and 11.97 [95% CI, 9.26-15.47], respectively). Recovered POS was also associated with greater risk of antibiotic exposure before 72 hours of life (ARR, 5.45 [95% CI, 3.94-7.52]) and need for respiratory support (ARR, 10.16 [3.53-29.21]) compared with a negative result. Respiratory disease was more common in newborns with recovered than negative POS results (27 [13.0%] vs 214 [1.3%]), as were sepsis (10 [4.8%] vs 127 [0.8%]) and hypoglycemia (17 [8.2%] vs 565 [3.5%]). No CCHD occurred among newborns with recovered POS.
CONCLUSIONS AND RELEVANCE: In this cohort study of neonates born at 35 weeks' gestation or later, those with initially indeterminate POS results that normalized on repeat testing had increased risks of treatable neonatal conditions and hospital care but not of CCHD. Further prospective studies should investigate whether targeted assessment of these newborns could reduce morbidity and prolonged hospitalization.
参考来源
- Karppi, Kiviranta, Sankilampi, et al. Clinical Outcomes After Recovered, Positive, and Negative Pulse Oximetry Screening Results Among Newborns. JAMA Netw Open. 2026. PMID: 42905704. doi:10.1001/jamanetworkopen.2026.39860
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。